ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VTRS Viatris Inc

10.961
-0.109 (-0.98%)
22 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Viatris Inc NASDAQ:VTRS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.109 -0.98% 10.961 10.96 11.01 11.08 10.885 11.04 6,631,387 00:47:05

Viatris to Release Third Quarter 2023 Financial Results on November 7, 2023

10/10/2023 2:29pm

PR Newswire (US)


Viatris (NASDAQ:VTRS)
Historical Stock Chart


From May 2023 to May 2024

Click Here for more Viatris Charts.

PITTSBURGH, Oct. 10, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its third quarter 2023 financial results on Tuesday, November 7 after the close of the U.S. financial markets. Chief Executive Officer Scott A. Smith, President Rajiv Malik, and Chief Financial Officer Sanjeev Narula also will host a webcast at 5:00 p.m. ET on November 7 to discuss the results.

Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 800.274.8461 or 203.518.9783 for international callers (Conference ID: VTRSQ323). A replay of the webcast also will be available on the website.

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life's moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter, LinkedIn, Instagram and YouTube.

Viatris Logo (PRNewsfoto/Viatris Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-release-third-quarter-2023-financial-results-on-november-7-2023-301952330.html

SOURCE Viatris Inc.

Copyright 2023 PR Newswire

1 Year Viatris Chart

1 Year Viatris Chart

1 Month Viatris Chart

1 Month Viatris Chart

Your Recent History

Delayed Upgrade Clock